Skip to main content
MedPathMedPath Home
Clinical Trials/NL-OMON42871
NL-OMON42871
Completed
Not Applicable

A randomised, subject-masked evaluation of visual function after bilateral implantation of two types of presbyopia-correcting multifocal intraocular lenses (IOLs): the Symfony-study - Symfony-study

Medisch Universitair Ziekenhuis Maastricht0 sites30 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditionspresbyopia and cataract surgeryage-related long sight and removal of the natural lens of the eye and implantation of an artificial lens10002693

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
presbyopia and cataract surgery
Sponsor
Medisch Universitair Ziekenhuis Maastricht
Enrollment
30
Status
Completed
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
January 1, 2019
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Medisch Universitair Ziekenhuis Maastricht

Eligibility Criteria

Inclusion Criteria

  • •\- Minimum 21 years of age
  • •\- Bilateral cataract
  • •\- Bilateral implantation of Tecnis Symfony or AT LISA tri 839 (same lens model in both eyes)
  • •\- Expected postoperative astigmatism \<\= 1\.00 D
  • •\- IOL power calculation between \+10\.00 D and 32\.00 D
  • •\- Expected postoperative best\-corrected visual acuity of logMAR \+0\.3 or better
  • •\- Availability to undergo second eye surgery within 2 weeks of the first eye surgery
  • •\- Willing and able to comply with scheduled visits and other study procedures
  • •\- Signed informed consent

Exclusion Criteria

  • •\- Previous corneal surgery and/or reshaping
  • •\- Clinically significant corneal endothelial dystrophy (e.g., Fuchs\* dystrophy)
  • •\- Irregular astigmatism
  • •\- History of corneal disease (e.g., herpes simplex, herpes zoster keratitis, etc.)
  • •\- Extensive age related macular degeneration (atrophic or exudative age\-related macular degeneration or numerous soft drusen)
  • •\- Extensive visual field loss (e.g., glaucoma, CVA, etc.)
  • •\- Extensive diabetic macular disease
  • •\- Amblyopia, strabismus
  • •\- Keratoconus
  • •\- Pseudoexfoliation syndrome or other capsule or zonular abnormalities that could affect postoperative centration or tilt of the IOL

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Phase 4
A randomized, subject-blinded evaluation of visual function after bilateral implantation of two types of presbyopia-correcting multifocal IOLsbilateral cataractpresbyopia10047518
NL-OMON37851Medisch Universitair Ziekenhuis Maastricht28
Recruiting
Not Applicable
A randomized, subject-blinded evaluation of visual function after bilateral implantation of two types of presbyopia-correcting multifocal IOLs.Correction of presbyopia after cataract surgery by multifocal intraocular lenses (IOLs)Correctie van presbyopie (ouderdomsverziendheid) na een cataractoperatie (staaroperatie) met intraoculaire implantlenzen (IOLs)
NL-OMON28310niversity Eye Clinic Maastricht, The Netherlands28
Recruiting
Not Applicable
Behavior of multiple sclerosis patients' view in computer useMultiple SclerosisC10.114.375.500
RBR-4m6zdhEscola de Artes, Ciências e Humanidade da Universidade São Paulo
Active, not recruiting
Phase 1
Amyloid imaging in Alzheimer’s disease, frontotemporal dementia and healthy volunteersse of 18F-AV-45 positron emission tomography as early diagnostic technique in frontal lobe dementia and Alzheimer's disease.MedDRA version: 14.0 Level: PT Classification code 10061816 Term: Diagnostic procedure System Organ Class: 10022891 - Investigations
EUCTR2008-003597-18-GBAvid Radiopharmaceuticals, Inc34
Completed
Phase 2
Amyloid imaging in Alzheimer's disease, frontotemporal dementia and healthy volunteersFrontotemporal dementia and Alzheimer's diseaseNervous System DiseasesAlzheimer's disease
ISRCTN58435532Avid Radiopharmaceuticals Inc.40